An Integrative Medicine Educational Program for Radiation Oncology Patients: Patient-Reported Outcomes

被引:0
|
作者
Fakhoury, Kareem R. [1 ]
Hu, Jungxiao [2 ]
Kim, Ellen [3 ]
Hansen, Kathryn A. [4 ]
Koval, Taylor R. [4 ]
Wolff, Kathleen [4 ]
-Pearce, Michelle C. Foote [4 ]
Karam, Sana Dole [1 ]
Stavas, Mark J. [5 ]
机构
[1] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80309 USA
[2] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA
[3] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA USA
[4] Vanderbilt Univ, Osher Ctr Integrat Hlth, Med Ctr, Nashville, TN USA
[5] Canc Partners Nebraska, Lincoln, NE USA
关键词
BREAST-CANCER PATIENTS; QUALITY-OF-LIFE; SUPPORTIVE CARE NEEDS; ALTERNATIVE MEDICINE; SELF-EFFICACY; LUNG-CANCER; COMPLEMENTARY; COMMUNICATION; DISCLOSURE; INFORMATION;
D O I
10.1016/j.adro.2023.101350
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Complementary health approaches (CHAs) equip patients to self -manage radiation therapy (RT)-related symptoms and fulfill unmet needs, but few disclose CHA use to their radiation oncologist. An integrative medicine educational program (IMEP) was developed to assess its ability to improve patient self -efficacy for symptom management and CHA use disclosure. Methods and Materials: The IMEP included 4 1 -hour sessions covering topics of (1) meditation, (2) yoga, (3) massage therapy, and (4) nutrition. Individuals over age 18 years and actively receiving RT were administered presession and postsession surveys. The primary outcomes were intention to disclose CHA use and self -efficacy. Qualitative data were assessed with a thematic approach. Results: Overall, 23 patients attended 1 or more sessions, yielding 43 completed surveys. Compared with 35.9% of participants who had disclosed CHA use before the session, 67.4% intended to disclose after the session. Of the 5 self -efficacy statements, there were significant improvements in "I have ownership over my health" (increase of 0.42; 95% CI, 0.07-0.77; P = .01), "I have tools to manage my disease on my own" (1.14; 95% CI, 0.42-1.87; P = .001), and "I have control over my cancer" (0.96; 95% CI, 0.39-1.53; P < .001). Barriers to involvement included transportation, timing relative to RT appointment, and poor performance status. Conclusions: A radiation -specific IMEP resulted in a high rate of intention to disclose CHA use and improvements in patients' reported self -efficacy to manage radiation -related symptoms. However, substantial resources were needed to deliver the IMEP. Future work must focus on increasing accessibility through telehealth and flexible timing. (c) 2023 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Health-Related Quality of Life and Patient-Reported Outcomes in Radiation Oncology Clinical Trials
    Remick, Jill S.
    Kowalski, Emily
    Samanta, Santanu
    Choi, Sung
    Palmer, Joshua D.
    Mishra, Mark V.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (11)
  • [32] Patient-Reported Outcomes in Surgical Oncology: An Overview of Instruments and Scores
    Joseph D. Phillips
    Sandra L. Wong
    [J]. Annals of Surgical Oncology, 2020, 27 : 45 - 53
  • [33] Patient-reported outcomes and the evolution of adverse event reporting in oncology
    Trotti, Andy
    Colevas, A. Dimitrios
    Setser, Ann
    Basch, Ethan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5121 - 5127
  • [34] Patient-Reported Outcomes in Oncology: Challenges and Opportunities for All Stakeholders
    Mitchell, Matthew
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2016, 9 (04): : 196 - +
  • [35] DEFINING REGULATORY SUCCESS FOR PATIENT-REPORTED OUTCOMES (PROS) IN ONCOLOGY
    Lenderking, W. R.
    Pokrzywinski, R. F.
    Currie, B.
    Wong, B.
    Park, J.
    Huang, H.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A430 - A430
  • [36] The impact of telemedicine on patient-reported outcomes in urologic oncology.
    Gadzinski, Adam John
    Abarro, Isabelle O.
    Stewart, Blair
    Gore, John L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] The impact of telemedicine on patient-reported outcomes in urologic oncology.
    Gadzinski, Adam John
    Abarro, Isabelle O.
    Stewart, Blair
    Gore, John L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [38] The role of patient-reported outcomes in evaluating the quality of oncology care
    Dennison, CR
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (18): : S580 - S586
  • [39] PATIENT-REPORTED OUTCOMES IN COMMERCIAL PEDIATRIC ONCOLOGY CLINICAL TRIALS
    Murugappan, M.
    King-Kallimanis, B. L.
    Reaman, G. H.
    Bhatnagar, V
    Horodniceanu, E. G.
    Bouchkouj, N.
    Kluetz, P. G.
    [J]. VALUE IN HEALTH, 2021, 24 : S59 - S59
  • [40] The Use of Patient-reported Outcomes in Demonstrating Safety and Efficacy in Oncology
    Coon, Cheryl D.
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (04) : 756 - 758